Stay updated on S64315 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S64315 Combo with Azacitidine in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure link along with the v3.3.2 revision entry were removed from the footer.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe Record History shows a new version entry: Revision v3.3.2 replacing v3.3.1, with no visible changes to study details or results. The footer and structure appear unchanged beyond the version note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page history shows a new version entry (v3.3.1) and removal of v3.2.0, with no changes to study records or primary content visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedDeleted the banner noting that information may be out of date due to government funding and potential operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check60 days agoChange DetectedThe new screenshot shows a slightly different header and reorganized page layout on the Record History page, with no changes to the study data or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

Stay in the know with updates to S64315 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.